Enzyme-Catalysed Spiroacetal Formation in Polyketide Antibiotic Biosynthesis

25 March 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A key step in the biosynthesis of numerous polyketides is the stereospecific formation of a spiroacetal (spiroketal). We report here that spiroacetal formation in the biosynthesis of the macrocyclic polyketides ossamycin and oligomycin involves catalysis by a novel spiroacetal cyclase. OssO from the ossamycin biosynthetic gene cluster (BGC) is homologous to OlmO, the product of an unannotated gene from the oligomycin BCG. Deletion of olmO abolished oligomycin production and led to the isolation of oligomycin-like metabolites lacking the spiroacetal structure. Purified OlmO catalysed complete conversion of the major metabolite into oligomycin C. Crystal structures of OssO and OlmO reveal an unusual 10-strand -barrel. Three conserved polar residues are clustered together in the -barrel cavity, and site-specific mutation of any of these residues either abolished or substantially diminished OlmO activity, supporting a role for general acid/general base catalysis in spiroacetal formation.

Keywords

spirocyclase
oligomycin
polyketide
calycin-like protein
natural product biosynthesis
ossamycin

Supplementary materials

Title
Description
Actions
Title
Enzyme-Catalysed Spiroacetal Formation in Polyketide Antibiotic Biosynthesis
Description
Experimental section, tables and figures
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.